These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36614095)

  • 1. CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells.
    Pietraforte I; Butera A; Gaddini L; Mennella A; Palazzo R; Campanile D; Stefanantoni K; Riccieri V; Lande R; Frasca L
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis.
    Lande R; Lee EY; Palazzo R; Marinari B; Pietraforte I; Santos GS; Mattenberger Y; Spadaro F; Stefanantoni K; Iannace N; Dufour AM; Falchi M; Bianco M; Botti E; Bianchi L; Alvarez M; Riccieri V; Truchetet ME; C L Wong G; Chizzolini C; Frasca L
    Nat Commun; 2019 May; 10(1):1731. PubMed ID: 31043596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
    Lande R; Mennella A; Palazzo R; Pietraforte I; Stefanantoni K; Iannace N; Butera A; Boirivant M; Pica R; Conrad C; Chizzolini C; Riccieri V; Frasca L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.
    Ah Kioon MD; Tripodo C; Fernandez D; Kirou KA; Spiera RF; Crow MK; Gordon JK; Barrat FJ
    Sci Transl Med; 2018 Jan; 10(423):. PubMed ID: 29321259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
    Ottria A; Zimmermann M; Paardekooper LM; Carvalheiro T; Vazirpanah N; Silva-Cardoso S; Affandi AJ; Chouri E; V D Kroef M; Tieland RG; Bekker CPJ; Wichers CGK; Rossato M; Mocholi-Gimeno E; Tekstra J; Ton E; van Laar JM; Cossu M; Beretta L; Garcia Perez S; Pandit A; Bonte-Mineur F; Reedquist KA; van den Bogaart G; Radstake TRDJ; Marut W
    Rheumatology (Oxford); 2022 May; 61(6):2682-2693. PubMed ID: 34559222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
    van Bon L; Affandi AJ; Broen J; Christmann RB; Marijnissen RJ; Stawski L; Farina GA; Stifano G; Mathes AL; Cossu M; York M; Collins C; Wenink M; Huijbens R; Hesselstrand R; Saxne T; DiMarzio M; Wuttge D; Agarwal SK; Reveille JD; Assassi S; Mayes M; Deng Y; Drenth JP; de Graaf J; den Heijer M; Kallenberg CG; Bijl M; Loof A; van den Berg WB; Joosten LA; Smith V; de Keyser F; Scorza R; Lunardi C; van Riel PL; Vonk M; van Heerde W; Meller S; Homey B; Beretta L; Roest M; Trojanowska M; Lafyatis R; Radstake TR
    N Engl J Med; 2014 Jan; 370(5):433-43. PubMed ID: 24350901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into dendritic cells in the pathogenesis of systemic sclerosis.
    Carvalheiro T; Zimmermann M; Radstake TRDJ; Marut W
    Clin Exp Immunol; 2020 Jul; 201(1):25-33. PubMed ID: 31970748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL4 Exposure Potentiates TLR-Driven Polarization of Human Monocyte-Derived Dendritic Cells and Increases Stimulation of T Cells.
    Silva-Cardoso SC; Affandi AJ; Spel L; Cossu M; van Roon JAG; Boes M; Radstake TRDJ
    J Immunol; 2017 Jul; 199(1):253-262. PubMed ID: 28515281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells in systemic sclerosis: Advances from human and mice studies.
    Affandi AJ; Carvalheiro T; Radstake TRDJ; Marut W
    Immunol Lett; 2018 Mar; 195():18-29. PubMed ID: 29126878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis.
    Silva IS; Ferreira BH; Almeida CR
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.
    Jiang Z; Chen C; Yang S; He H; Zhu X; Liang M
    J Dermatol Sci; 2021 Oct; 104(1):63-73. PubMed ID: 34556381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL4 is a driver of cytokine mRNA stability in monocyte-derived dendritic cells.
    Silva-Cardoso SC; Bekker CPJ; Boes M; Radstake TRDJ; Angiolilli C
    Mol Immunol; 2019 Oct; 114():524-534. PubMed ID: 31518856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?
    van Bon L; Cossu M; Scharstuhl A; Pennings BW; Vonk MC; Vreman HJ; Lafyatis RL; van den Berg W; Wagener FA; Radstake TR
    Rheumatology (Oxford); 2016 Nov; 55(11):2066-2073. PubMed ID: 27411481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis.
    van der Kroef M; Carvalheiro T; Rossato M; de Wit F; Cossu M; Chouri E; Wichers CGK; Bekker CPJ; Beretta L; Vazirpanah N; Trombetta E; Radstake TRDJ; Angiolilli C
    J Autoimmun; 2020 Jul; 111():102444. PubMed ID: 32284212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis.
    Lande R; Palazzo R; Mennella A; Pietraforte I; Cadar M; Stefanantoni K; Conrad C; Riccieri V; Frasca L
    Antibodies (Basel); 2021 Mar; 10(2):. PubMed ID: 33800661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells
    Silva-Cardoso SC; Tao W; Angiolilli C; Lopes AP; Bekker CPJ; Devaprasad A; Giovannone B; van Laar J; Cossu M; Marut W; Hack E; de Boer RJ; Boes M; Radstake TRDJ; Pandit A
    Front Immunol; 2020; 11():2149. PubMed ID: 33042127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses.
    Chaudhary V; Ah Kioon MD; Hwang SM; Mishra B; Lakin K; Kirou KA; Zhang-Sun J; Wiseman RL; Spiera RF; Crow MK; Gordon JK; Cubillos-Ruiz JR; Barrat FJ
    J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36053251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients' Cohort.
    Palazzo R; Stefanantoni K; Cadar M; Butera A; Riccieri V; Lande R; Frasca L
    Antibodies (Basel); 2022 Dec; 11(4):. PubMed ID: 36546902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.